bioRxiv Science⌕ Search

Biology subjects

Crosslin, D.

Publications and source records attributed to Crosslin, D..

2 recordsLinked to original sources

Using user-centered design to better understand challengesfaced during genetic analyses by novice genomicresearchers

The lack of user-centered design principles in the current landscape of commonly-used bioinformatics software tools poses challenges for novice genomics researchers (NGRs) entering the genomics ecosystem. Comparing the usability of one analysis software to that of another is a non-trivial task and requires evaluation criteria that incorporates perspectives from both existing literature and a diverse, underrepresented user base of NGRs. To better characterize these barriers, we utilized a two-pronged approach consisting of a literature review of existing bioinformatics tools and semi-structured interviews of the needs of NGRs. From both knowledge sources, the key attributes that resulted in poor adoption and sustained use of most bioinformatics tools included poor documentation, lack of readily-accessible informational content, challenges with installation and dependency coordination, and inconsistent error messages/progress indicators. Combining the findings from the literature review and the insights gained by interviewing the NGRs, an evaluation rubric was created that can be utilized to grade existing and future bioinformatics tools. This rubric acts as a summary of key components needed for software tools to cater to the diverse needs of both NGRs and experienced users. Due to the rapidly evolving nature of genomics research, it becomes increasingly important to critically evaluate existing tools and develop new ones that will help build a strong foundation for future exploration.

bioinformatics↗

Atlas-CNV: a validated approach to call Single-Exon CNVs in the eMERGESeq gene panel

PurposeTo provide a validated method to confidently identify exon-containing copy number variants (CNVs), with a low false discovery rate (FDR), in targeted sequencing data from a clinical laboratory with particular focus on single-exon CNVs.\n\nMethodsDNA sequence coverage data are normalized within each sample and subsequently exonic CNVs are identified in a batch of samples (midpool), when the target log2 ratio of the sample to the batch median exceeds defined thresholds. The quality of exonic CNV calls is assessed by C-scores (Z-like scores) using thresholds derived from gold standard samples and simulation studies. We integrate an ExonQC threshold to lower FDR and compare performance with alternate software (VisCap).\n\nResultsThirteen CNVs were used as a truth set to validate Atlas-CNV and compared with VisCap. We demonstrated FDR reduction in validation, simulation and 10,926 eMERGESeq samples without sensitivity loss. Sixty-four multi-exon and 29 single-exon CNVs with high C-scores were assessed by MLPA.\n\nConclusionsAtlas-CNV is validated as a method to identify exonic CNVs in targeted sequencing data generated in the clinical laboratory. The ExonQC and C-score assignment can reduce FDR (identification of targets with high variance) and improve calling accuracy of single-exon CNVs respectively. We proposed guidelines and criteria to identify high confidence single-exon CNVs.

genomics↗